Mesoblast Limited (MESO)
NASDAQ: MESO · Real-Time Price · USD
14.78
+0.15 (1.03%)
At close: Mar 19, 2026, 4:00 PM EDT
14.78
0.00 (0.00%)
After-hours: Mar 19, 2026, 5:51 PM EDT
Mesoblast Market Cap
Mesoblast has a market cap or net worth of $1.9 billion as of March 19, 2026. Its market cap has increased by 12.34% in one year.
Market Cap
1.90B
Enterprise Value
1.91B
1-Year Change
12.34%
Ranking
Category
Stock Price
$14.78
Market Cap Chart
Since November 13, 2015, Mesoblast's market cap has increased from $593.20M to $1.90B, an increase of 221.04%. That is a compound annual growth rate of 11.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 1.89B | -18.36% |
| Dec 31, 2025 | 2.31B | 2.14% |
| Dec 31, 2024 | 2.26B | 1,162.26% |
| Dec 29, 2023 | 179.10M | -58.22% |
| Dec 30, 2022 | 428.70M | -31.15% |
| Dec 31, 2021 | 622.70M | -37.40% |
| Dec 31, 2020 | 994.70M | 35.19% |
| Dec 31, 2019 | 735.80M | 84.92% |
| Dec 31, 2018 | 397.90M | -27.59% |
| Dec 29, 2017 | 549.50M | 34.55% |
| Dec 30, 2016 | 408.40M | -12.21% |
| Dec 31, 2015 | 465.20M | -21.58% |
| Nov 13, 2015 | 593.20M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celldex Therapeutics | 2.01B |
| Stoke Therapeutics | 2.01B |
| Tyra Biosciences | 1.99B |
| Aurinia Pharmaceuticals | 1.90B |
| Ocular Therapeutix | 1.88B |
| AnaptysBio | 1.86B |
| Definium Therapeutics | 1.83B |
| Relay Therapeutics | 1.81B |